Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-22

Clinical Trial Update: Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study [Phase 4]

View source ↗

Summary

Phase 4 placebo-controlled trial evaluating oxybutynin for hyperhidrosis has completed; the provided snippet does not include trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oxybutynin (oxybutynin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Hyperhidrosis | Phase 4 | Status: COMPLETED